Pulmonx (LUNG) Assets Average (2020 - 2025)

Pulmonx (LUNG) has reported Assets Average for 6 consecutive years, with $133.8 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Assets Average fell 18.98% year-over-year to $133.8 million in Q4 2025; TTM through Dec 2025 was $133.8 million, a 18.98% decrease from a year earlier, with the FY2025 full-year figure at $146.1 million, down 14.24% from the prior year.
• Assets Average was $133.8 million for Q4 2025 at Pulmonx, down from $142.7 million in the prior quarter.
• Over five years, Assets Average peaked at $259.5 million in Q1 2021 and troughed at $133.8 million in Q4 2025.
• A 5-year average of $193.8 million and a median of $193.1 million in 2023 frame the typical range for Assets Average.
• Across the five-year window, Assets Average jumped 43.9% in 2021 and retreated 18.98% in 2025, its largest moves.
• Over 5 years, Assets Average stood at $241.0 million in 2021, then dropped by 17.87% to $197.9 million in 2022, then decreased by 8.36% to $181.4 million in 2023, then decreased by 8.97% to $165.1 million in 2024, then dropped by 18.98% to $133.8 million in 2025.
• The last three Assets Average figures came in at $133.8 million (Q4 2025), $142.7 million (Q3 2025), and $149.0 million (Q2 2025), per Business Quant data.